The platform for submitting project applications for the Joint Transnational Call for Proposals (JTC) 2025 entitled “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation” is now officially live.
The platform will allow you to:
Register and provide all required personal data for project participants.
Enter your finalised project description.
Access to the platform can be found here. We strongly recommend registering early to familiarise yourself with the platform’s functionality.
The JTC 2025 will follow a two-stage submission process:
13 February 2025: Pre-proposal submission deadline
9 July 2025: Full proposals submission deadline
Funding decisions are expected by December 2025.
For further details, access the updated call documents here.